Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Comparison of vitamin D3 serum levels in new diagnosed patients with multiple sclerosis versus their healthy relatives.

Mazdeh M, Seifirad S, Kazemi N, Seifrabie MA, Dehghan A, Abbasi H.

Acta Med Iran. 2013 May 30;51(5):289-92.

2.

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.

Hiremath GS, Cettomai D, Baynes M, Ratchford JN, Newsome S, Harrison D, Kerr D, Greenberg BM, Calabresi PA.

Mult Scler. 2009 Jun;15(6):735-40. doi: 10.1177/1352458509102844. Epub 2009 Apr 21.

PMID:
19383644
3.

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.

Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):152-7. Epub 2007 Jun 19.

PMID:
17578859
4.

Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.

Martinelli V, Dalla Costa G, Colombo B, Dalla Libera D, Rubinacci A, Filippi M, Furlan R, Comi G.

Mult Scler. 2014 Feb;20(2):147-55. doi: 10.1177/1352458513494959. Epub 2013 Jul 8.

PMID:
23836877
5.

Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.

Décard BF, von Ahsen N, Grunwald T, Streit F, Stroet A, Niggemeier P, Schottstedt V, Riggert J, Gold R, Chan A.

J Neurol Neurosurg Psychiatry. 2012 Dec;83(12):1170-3. doi: 10.1136/jnnp-2012-303068. Epub 2012 Aug 11.

PMID:
22888143
6.

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

Soilu-Hänninen M, Aivo J, Lindström BM, Elovaara I, Sumelahti ML, Färkkilä M, Tienari P, Atula S, Sarasoja T, Herrala L, Keskinarkaus I, Kruger J, Kallio T, Rocca MA, Filippi M.

J Neurol Neurosurg Psychiatry. 2012 May;83(5):565-71. doi: 10.1136/jnnp-2011-301876. Epub 2012 Feb 22.

PMID:
22362918
7.

Vitamin D levels in Hispanics with multiple sclerosis.

Amezcua L, Chung RH, Conti DV, Langer-Gould AM.

J Neurol. 2012 Dec;259(12):2565-70. doi: 10.1007/s00415-012-6537-z. Epub 2012 May 16.

PMID:
22588255
8.

Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity.

Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y.

J Bone Miner Metab. 2005;23(4):309-13.

PMID:
15981027
9.

Serum alkaline phosphatase screening for vitamin D deficiency states.

Shaheen S, Noor SS, Barakzai Q.

J Coll Physicians Surg Pak. 2012 Jul;22(7):424-7. doi: 07.2012/JCPSP.424427.

PMID:
22747860
10.

Safety of vitamin D3 in adults with multiple sclerosis.

Kimball SM, Ursell MR, O'Connor P, Vieth R.

Am J Clin Nutr. 2007 Sep;86(3):645-51.

11.

Immunomodulatory effects of Vitamin D in multiple sclerosis.

Correale J, Ysrraelit MC, Gaitán MI.

Brain. 2009 May;132(Pt 5):1146-60. doi: 10.1093/brain/awp033. Epub 2009 Mar 24.

PMID:
19321461
12.

Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta.

Åivo J, Hänninen A, Ilonen J, Soilu-Hänninen M.

J Neuroimmunol. 2015 Mar 15;280:12-5. doi: 10.1016/j.jneuroim.2015.01.005. Epub 2015 Jan 21.

PMID:
25773149
13.

Role of vitamin D in the onset, progression, and severity of multiple sclerosis.

Mesliniene S, Ramrattan L, Giddings S, Sheikh-Ali M.

Endocr Pract. 2013 Jan-Feb;19(1):129-36. doi: 10.4158/EP12152.RA. Review.

PMID:
23186958
14.

Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women.

Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, Polman Ch, Lips P.

Mult Scler. 2009 Jan;15(1):9-15. doi: 10.1177/1352458508095920. Epub 2008 Aug 13.

PMID:
18701572
15.

Sun exposure and vitamin D are independent risk factors for CNS demyelination.

Lucas RM, Ponsonby AL, Dear K, Valery PC, Pender MP, Taylor BV, Kilpatrick TJ, Dwyer T, Coulthard A, Chapman C, van der Mei I, Williams D, McMichael AJ.

Neurology. 2011 Feb 8;76(6):540-8. doi: 10.1212/WNL.0b013e31820af93d.

PMID:
21300969
16.

Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers.

Karatekin G, Kaya A, Salihoğlu O, Balci H, Nuhoğlu A.

Eur J Clin Nutr. 2009 Apr;63(4):473-7. Epub 2007 Nov 21.

PMID:
18030309
17.

Assessment of immune status in relation to vitamin D levels in children on regular hemodialysis.

Youssef DM, Elshal AS, Abo Elazem AA.

Saudi J Kidney Dis Transpl. 2012 Mar;23(2):267-73.

18.

Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue.

Knippenberg S, Bol Y, Damoiseaux J, Hupperts R, Smolders J.

Acta Neurol Scand. 2011 Sep;124(3):171-5. doi: 10.1111/j.1600-0404.2010.01447.x. Epub 2010 Sep 29.

PMID:
20880265
19.

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.

Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, Ghazi-Visser L, Beelke M; SOLAR study group..

J Neurol Sci. 2011 Dec 15;311(1-2):44-9. doi: 10.1016/j.jns.2011.04.013. Epub 2011 May 28.

PMID:
21620416
20.

Vitamin D and autoimmune disease--implications for practice from the multiple sclerosis literature.

Mark BL, Carson JA.

J Am Diet Assoc. 2006 Mar;106(3):418-24. Review.

PMID:
16503232

Supplemental Content

Support Center